10X Genomics Inc (Class A)

2026. szept. 23. 20:02 UTC

10X Genomics Inc shares fell sharply on Wednesday, breaking a recent trend of higher daily closes amid unusually high market volume.

2026. szept. 22. 20:07 UTC

10X Genomics Inc is advancing during Tuesday's session, supported by positive social media sentiment and remaining above its 20-day moving average.

2026. szept. 21. 23:06 UTC

10X Genomics Inc saw routine after-market trading with price movement remaining roughly flat, following a strong one-month performance above its 20-day moving average.

2026. szept. 18. 19:16 UTC

10X Genomics Inc shares fell sharply, retracing from an earlier high, despite remaining above the 20-day moving average and near the upper end of its one-month range.

2026. szept. 17. 23:06 UTC

10X Genomics Inc has seen modest gains in after-market trading, remaining significantly above its 20-day moving average and near the upper end of its one-month range.

2026. szept. 16. 19:22 UTC

10X Genomics Inc shares fell sharply during Wednesday's trading session after an initial gain, reflecting notable volatility and a decline since Tuesday's close.

2026. szept. 15. 23:02 UTC

10X Genomics Inc shares are higher in after-market trading, reflecting overall positive market sentiment despite recent declines in manufacturing and rising crude oil inventories.

2026. szept. 14. 23:06 UTC

10X Genomics Inc. shares are lower in after-market trading, aligning with a broader U.S. market decline amid rising crude oil prices due to supply concerns.

2026. szept. 11. 20:08 UTC

10X Genomics Inc. is rising today, supported by positive social media sentiment and strong trading momentum above key moving averages.

2026. szept. 10. 23:26 UTC

10X Genomics shares advanced in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

2026. szept. 9. 19:56 UTC

UBS raised its price target for 10X Genomics to $68, maintaining a Neutral rating. The stock is trading higher amid positive social media discussions.

2026. szept. 8. 20:07 UTC

10X Genomics raises 2026 revenue guidance to $610 million-$630 million, driving shares higher during trading. Analysts express concerns about potential overvaluation.

2026. szept. 2. 20:08 UTC

10X Genomics Inc. shares are higher today, driven by significant gains in the Life Sciences Tools & Services sub-sector. No specific company news was identified.

2026. szept. 1. 20:04 UTC

10X Genomics Inc shares are lower after RBC Capital initiated coverage with a Sector Perform rating and a $70 price target. Rising oil prices add to inflation concerns.

2026. aug. 31. 20:07 UTC

10X Genomics awarded over $4.8 million in damages by jury for patent infringement. Analysts see potential for favorable outcomes, boosting shares higher today.

2026. aug. 28. 23:46 UTC

10X Genomics Inc is trading higher in after-market hours, reflecting positive market performance amid rising Treasury yields and increased rate hike expectations.

2026. aug. 26. 19:36 UTC

10X Genomics Inc shares are lower today, reaching a session low earlier. Broader inflation data may impact Federal Reserve policy decisions.

2026. aug. 25. 23:21 UTC

10X Genomics Inc shares are higher in after-market hours, though no specific news was identified. Market sentiment improved amid a decline in crude oil prices.

2026. aug. 24. 19:26 UTC

10X Genomics Inc shares are lower today amid broader market declines and geopolitical tensions, though the stock remains significantly above its 20-day moving average.

2026. aug. 21. 23:16 UTC

10X Genomics Inc. shares are higher in after-market trading, continuing gains since Friday's close, amid broader cryptocurrency market strength.

2026. aug. 20. 23:16 UTC

10X Genomics Inc. shares traded lower after-market, amid broader market pressure from rising bond yields and concerns over high borrowing costs and geopolitical risks.

2026. aug. 19. 23:06 UTC

10X Genomics Inc shares are higher in after-market trading, reflecting strong momentum above the 20-day moving average and near the top of its one-month range.

2026. aug. 18. 23:31 UTC

10X Genomics Inc shares are higher in after-market trading, maintaining a notable increase while staying above the 20-day moving average. No specific news was identified.

2026. aug. 17. 19:16 UTC

10X Genomics Inc shares are higher today, recovering from an initial dip. The stock remains above its 20-day moving average amid mixed economic indicators.

2026. aug. 14. 20:06 UTC

10X Genomics Inc shares are lower today amid mixed market sentiment following a reported decline in U.S. retail sales for July.

2026. aug. 13. 19:16 UTC

10X Genomics Inc reported Q2 revenue of $151 million, exceeding estimates. Shares are higher as management raises full-year revenue guidance to $620 million.

2026. aug. 12. 19:46 UTC

10X Genomics Inc. shares are lower today, having retraced from an early peak. The stock remains above its 20-day moving average.

2026. aug. 11. 20:06 UTC

10X Genomics Inc. shares are lower today amid routine trading, despite earlier fluctuations and remaining above the 20-day moving average.

2026. aug. 10. 20:03 UTC

10X Genomics shares rise as Piper Sandler and Canaccord Genuity raise price targets to $47.00 and $60.00, respectively, amid increased trading volume.

2026. aug. 7. 23:16 UTC

10X Genomics Inc shares are lower in after-market trading amid a sector decline. Citigroup raised its price target to $50 while maintaining a Neutral rating.